Areas of Focus
- Cardiovascular Pharmacology
Work Experience
- 2018.7-2022.6 Postdoctoral Researcher, Department of Physiology and Pathophysiology, Peking University
- 2022.7-2023.3 Research Assistant, Department of Physiology and Pathophysiology, Peking University
- 2023.4-present Associate Researcher, Department of Pharmacology, School of Basic Medical Sciences, Peking University
Academic Background & Achievements
- 2010.9-2015.6 Bachelor in Basic Medicine (Eight-year program), Peking University
- 2015.9-2018.6 PhD in Human Physiology, Peking University
- Published 15 SCI papers in the past five years, including works in top cardiovascular journals
- Principal investigator for national youth projects and Peking University 'Med-X' projects
Publications
- PHB2 Maintains the Contractile Phenotype of VSMCs by Counteracting PKM2 Splicing, Jia Y, Mao C, Ma Z, Huang J, Li W, Ma X, Zhang S, Li M, Yu F, Sun Y, Chen J, Feng J, Zhou Y, Xu Q, Zhao L, Fu Y, Kong W, 2022
- Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm, Jia Y, Zhang L, Liu Z, Mao C, Ma Z, Li W, Yu F, Wang Y, Huang Y, Zhang W, Zheng J, Wang X, Xu Q, Zhang J, Feng W, Yun C, Liu C, Sun J, Fu Y, Cui Q, Kong W, 2022
- Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling, Mao C, Ma Z, Jia Y, Li W, Xie N, Zhao G, Ma B, Yu F, Sun J, Zhou Y, Cui Q, Fu Y, Kong W, 2021
- COMP-prohibitin 2 interaction maintains mitochondrial homeostasis and controls smooth muscle cell identity, Jia Y, Wang M, Mao C, Yu F, Wang Y, Xiao R, Jiang C, Zheng L, Xu Q, Zheng M, Fu Y, Hu Q, Kong W, 2018
- ADAM17: A Molecular Switch to Control TNFR2 During Atherogenesis In Vivo, Jia Y, Kong W, 2017